4.6 Article

Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome

期刊

BRITISH JOURNAL OF OPHTHALMOLOGY
卷 106, 期 4, 页码 576-581

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bjophthalmol-2019-315550

关键词

retina; imaging; macula; choroid

资金

  1. Heidelberg Engineering
  2. Carl Zeiss Meditec
  3. Optos
  4. Centervue
  5. Novartis
  6. Bayer
  7. Boeheringer
  8. Allergan
  9. Alcon
  10. Topcon
  11. Nidek
  12. Macula Foundation Inc, New York NY

向作者/读者索取更多资源

The long-term anatomic and visual outcomes of patients with peripapillary pachychoroid syndrome (PPS) were analyzed in this study. The study found that patients with PPS experienced decreased retinal oedema and choroidal thickening throughout the course of the disease. While some patients may experience visual decline, the overall visual outcome was relatively favorable and independent of trends in retinal or choroidal thickening.
Background/Aims To analyse the long-term anatomic and visual outcomes of patients with peripapillary pachychoroid syndrome (PPS), a recently described entity in the pachychoroid disease spectrum. Methods This study retrospectively included patients from several retina centres worldwide. Visual acuity (VA), retinal thickness and choroidal thickness at baseline, 6 months and final follow-up were assessed. Temporal trends in VA and anatomic characteristics were evaluated. Visual and anatomic outcomes in eyes that were observed versus those that were treated were analysed. Results Fifty-six eyes of 35 patients were included with mean follow-up of 27 +/- 17 months. Median VA was 20/36 at baseline and remained stable through follow-up (p=0.77). Retinal thickness significantly decreased subfoveally (p=0.012), 1.5 mm nasal to the fovea (p=0.002) and 3.0 mm nasal to the fovea (p=0.0035) corresponding to areas of increased thickening at baseline. Choroidal thickness significantly decreased subfoveally (p=0.0030) and 1.5 mm nasal to the fovea (p=0.0030). Forty-three eyes were treated with modalities including antivascular endothelial growth factor injection, photodynamic therapy, and others. VA remained stable in treated eyes over follow-up (p=0.67). An isolated peripapillary fluid pocket in the outer nuclear layer was characteristic of PPS. Conclusion Patients with PPS experienced decreased retinal oedema and decreased choroidal thickening throughout the course of disease. While some patients experienced visual decline, the overall visual outcome was relatively favourable and independent of trends in retinal or choroidal thickening.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据